Literature DB >> 17187566

Infectious clones of Chikungunya virus (La Réunion isolate) for vector competence studies.

Konstantin Tsetsarkin1, Stephen Higgs, Charles E McGee, Xavier De Lamballerie, Remi N Charrel, Dana L Vanlandingham.   

Abstract

The recent outbreak of Chikungunya virus (CHIKV) on several islands in the Indian Ocean and in India has focused attention on this reemerging virus and highlighted the need for development of new tools to study vector-virus-host interactions. We have constructed and characterized, in cell culture, Aedes aegypti and Ae. albopictus mosquitoes, infectious cDNA clones of CHIKV using a recent isolate from La Réunion Island. Comparison of the growth kinetics and infection rates of the viral isolate CHIKV strain LR2006 OPY1 (CHIKV-LR) and a full-length infectious clone (CHIKV-LR ic) indicate that the infectious clone has retained the viral phenotypes of the original isolate. Infectious clones that express green fluorescent protein (GFP) were also produced and characterized in cell culture and in Aedes mosquitoes. The CHIKV-LR 5'GFP infected Ae. aegypti and Ae. albopictus mosquitoes at a similar rate to the original virus and to the full length infectious clone. The CHIKV-LR 3'GFP only infected Ae. albopictus mosquitoes at similar rates. The development of these authentic infectious clones will enable targeted studies of the molecular determinants of infection, pathogenesis and transmission competence by Ae. aegypti and Ae. albopictus mosquitoes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187566     DOI: 10.1089/vbz.2006.6.325

Source DB:  PubMed          Journal:  Vector Borne Zoonotic Dis        ISSN: 1530-3667            Impact factor:   2.133


  110 in total

1.  Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus.

Authors:  Justin R Darwin; Joan L Kenney; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes.

Authors:  Konstantin A Tsetsarkin; Rubing Chen; Grace Leal; Naomi Forrester; Stephen Higgs; Jing Huang; Scott C Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

4.  Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.

Authors:  Ellen M Bouma; Denise P I van de Pol; Ilson D Sanders; Izabela A Rodenhuis-Zybert; Jolanda M Smit
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

5.  Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.

Authors:  Chad J Roy; A Paige Adams; Eryu Wang; Kenneth Plante; Rodion Gorchakov; Robert L Seymour; Heather Vinet-Oliphant; Scott C Weaver
Journal:  J Infect Dis       Date:  2014-01-07       Impact factor: 5.226

6.  Infection of Aedes albopictus with chikungunya virus rectally administered by enema.

Authors:  John T Nuckols; Sarah A Ziegler; Yan-Jang Scott Huang; Alex J McAuley; Dana L Vanlandingham; Marc J Klowden; Heidi Spratt; Robert A Davey; Stephen Higgs
Journal:  Vector Borne Zoonotic Dis       Date:  2012-12-18       Impact factor: 2.133

7.  Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro.

Authors:  John W Schoggins; Marcus Dorner; Michael Feulner; Naoko Imanaka; Mary Y Murphy; Alexander Ploss; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

8.  Development of infectious cDNA clones of Salmonid alphavirus subtype 3.

Authors:  Marius Karlsen; Stephane Villoing; Karl F Ottem; Espen Rimstad; Are Nylund
Journal:  BMC Res Notes       Date:  2010-09-21

9.  Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus.

Authors:  Saravanan Thangamani; Stephen Higgs; Sarah Ziegler; Dana Vanlandingham; Robert Tesh; Stephen Wikel
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

10.  Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes.

Authors:  Konstantin A Tsetsarkin; Charles E McGee; Sara M Volk; Dana L Vanlandingham; Scott C Weaver; Stephen Higgs
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.